Loss of detoxification in inflammatory bowel disease

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 3, Issue 7, 2006, Pages 358-359

  Langmann, Thomas ^a,b   Schmitz, Gerd ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AROMATIC HYDROCARBON RECEPTOR; BILE ACID; BREAST CANCER RESISTANCE PROTEIN; CYTOCHROME P450 2C; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DRUG METABOLIZING ENZYME; GLUCURONIDE; GLUTATHIONE; HYODEOXYCHOLIC ACID; LITHOCHOLIC ACID; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PREGNANE X RECEPTOR; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; RIFAMPICIN; STEROID RECEPTOR; SULFIDE; TRANSCRIPTION FACTOR; URSODEOXYCHOLIC ACID; XENOBIOTIC AGENT;

ACETYLATION; BILE ACID BLOOD LEVEL; BIOTRANSFORMATION; CATALYSIS; CONJUGATION; CROHN DISEASE; DETOXIFICATION; DISEASE PREDISPOSITION; ENTERITIS; ENZYME ACTIVATION; EPITHELIUM CELL; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; INTESTINE BIOPSY; INTESTINE CELL; INTESTINE EPITHELIUM; LIPOGENESIS; MACROPHAGE; MICROVILLUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUTRITION; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; METABOLIC DETOXICATION, DRUG; METABOLIC DETOXICATION, PHASE I; XENOBIOTICS;

EID: 33745797054     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0545     Document Type: Review

References (10)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429
2. Crotty B (1994) Ulcerative colitis and xenobiotic metabolism. Lancet 343: 35-38
3. Langmann T et al. (2004) Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane receptor target genes. Gastroenterology 127: 26-40
4. Dring MM et al. (2006) The pregnane receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130: 341-348
5. Kaminsky LS and Zang Q (2003) The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos 31: 1520-1525
6. Kliewer SA et al. (2002) The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism. Endocr Rev 23: 687-702
7. Roediger WE et al. (1997) Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 42: 1571-1579
8. Panwala CM et al. (1998) A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. J Immunol 161: 5733-5744
9. Brant SR et al. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73: 1282-1292
10. Marschall HU et al. (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129: 476-485